M.D.C. (NYSE:MDC) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of M.D.C. (NYSE:MDCFree Report) in a research note published on Friday. The brokerage issued a hold rating on the construction company’s stock.

Several other analysts also recently weighed in on MDC. Evercore ISI downgraded shares of M.D.C. from an outperform rating to an in-line rating and lifted their price target for the company from $57.00 to $63.00 in a research note on Wednesday, January 31st. Raymond James reaffirmed a market perform rating on shares of M.D.C. in a research note on Wednesday, February 7th. One analyst has rated the stock with a sell rating and five have given a hold rating to the stock. According to MarketBeat.com, M.D.C. presently has an average rating of Hold and a consensus target price of $52.13.

Check Out Our Latest Analysis on M.D.C.

M.D.C. Price Performance

Shares of NYSE MDC opened at $62.98 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 9.76 and a quick ratio of 3.92. The company has a market cap of $4.73 billion, a P/E ratio of 11.93 and a beta of 1.54. M.D.C. has a 1 year low of $36.47 and a 1 year high of $63.00. The firm has a 50-day simple moving average of $62.72 and a two-hundred day simple moving average of $53.82.

M.D.C. (NYSE:MDCGet Free Report) last announced its quarterly earnings data on Tuesday, January 30th. The construction company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.50 by $0.06. M.D.C. had a net margin of 8.64% and a return on equity of 12.32%. The business had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter last year, the firm earned $1.08 earnings per share. The firm’s quarterly revenue was down 11.9% compared to the same quarter last year. Research analysts anticipate that M.D.C. will post 5.7 earnings per share for the current year.

Insider Buying and Selling

In related news, Director David E. Blackford sold 6,200 shares of the business’s stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $62.69, for a total value of $388,678.00. Following the completion of the transaction, the director now owns 13,534 shares of the company’s stock, valued at $848,446.46. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 23.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On M.D.C.

Large investors have recently bought and sold shares of the business. Oppenheimer & Co. Inc. grew its holdings in M.D.C. by 0.6% in the fourth quarter. Oppenheimer & Co. Inc. now owns 34,954 shares of the construction company’s stock worth $1,931,000 after purchasing an additional 198 shares during the last quarter. SummerHaven Investment Management LLC grew its holdings in M.D.C. by 1.4% in the fourth quarter. SummerHaven Investment Management LLC now owns 15,308 shares of the construction company’s stock worth $846,000 after purchasing an additional 205 shares during the last quarter. Arden Trust Co grew its holdings in M.D.C. by 5.3% in the first quarter. Arden Trust Co now owns 4,570 shares of the construction company’s stock worth $288,000 after purchasing an additional 232 shares during the last quarter. Ronald Blue Trust Inc. grew its holdings in M.D.C. by 100.0% in the third quarter. Ronald Blue Trust Inc. now owns 640 shares of the construction company’s stock worth $26,000 after purchasing an additional 320 shares during the last quarter. Finally, Nilsine Partners LLC grew its holdings in M.D.C. by 6.9% in the fourth quarter. Nilsine Partners LLC now owns 5,353 shares of the construction company’s stock worth $296,000 after purchasing an additional 344 shares during the last quarter. Institutional investors own 88.08% of the company’s stock.

About M.D.C.

(Get Free Report)

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Featured Stories

Analyst Recommendations for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.